http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106943344-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4015 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015 |
| filingDate | 2016-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106943344-B |
| titleOfInvention | A kind of -2 oxo-1-pyrrolidine ethanamide injection of (S) -4- hydroxyl and preparation method thereof that stability is good |
| abstract | A kind of (S)-Olaxiracetam of injection, it is made by following supplementary material: (S)-Olaxiracetam 65% ~ 85%, propylene glycol 8% ~ 25%, lecithin 5% ~ 25%, benzyl alcohol 1% ~ 5%；It is substantially unchanged according to pH value of solution in (S)-Olaxiracetam injection sterilization process produced by the present invention, product stability is good, crystallization will not be generated during storage, validity period is long, it can reach 18 months or more, product impurity is few in validity period, and total impurities are lower than 0.36%, feeling of pain reduces in patient injection procedure, good patient compliance. |
| priorityDate | 2016-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 45.